Letter to Editor: Avoiding statistical pitfalls when assessing the performance of risk prediction nomograms.

Varey AHR, Thompson JF, Lo SN

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial.

Tie J, Wang Y, Lo SN, Lahouel K, Cohen JD, Wong R, Shapiro JD, Harris SJ, Khattak A, Burge ME, Lee M, Harris M, McLachlan SA, Horvath L, Karapetis C, Shannon J, Singh M, Yip D, Ananda S, Underhill C, Ptak J, Silliman N, Dobbyn L, Popoli M, Papadopoulos N, Tomasetti C, Kinzler KW, Vogelstein B, Gibbs P

Protocolised Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock in Australia-Initial Experience From a Hub-and-Spoke Model.

Backhouse B, Dade F, Bloom JE, Xiao X, Haji K, Yang Y, French C, Stub D, Nanjayya V, Lo S, Chiang M, Basir MB, O'Neill W, Noaman S, Al-Mukhtar O, Kaye D, Cox N, Chan W

Response to Chen et al, "Comments on the increased risk of hidradenitis suppurativa in patients with human papillomavirus infection".

Chang HC, Lo SW, Hsu C, Chen SJ, Zuberbier T, Gau SY

Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas.

Perlow HK, Raleigh DR, Wang TJC, Pollom EL, Milano MT, Breen WG, Detsky J, Chang EL, Tom MC, Shiue KR, Lehrer EJ, Saeed H, Pike LRG, Lo SS, Mishra MV, Knisely JPS, Chao ST, Sahgal A, Palmer JD

Response to Han and Liu.

Lo SN, Varey AHR, Ch'ng S, Scolyer RA, Thompson JF

Comparison of clinical and laboratory data between hantavirus infection and leptospirosis: a retrospective case series study in southern Taiwan.

Lo SH, Chen TC, Lin CY, Hsieh HC, Lai PC, Lien WL, Yeh YC, Lee IK, Chen YH, Lu PL, Chang K

Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST.

Valenzuela RF, Duran-Sierra E, Antony M, Amini B, Lo S, Torres KE, Benjamin RS, Ma J, Hwang KP, Stafford RJ, Araujo D, Bishop AJ, Ratan R, Wang WL, Espinoza J, Valenzuela PV, Wu C, Madewell JE, Murphy WA Jr, Costelloe CM

Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers.

Rodriguez CP, Wu QV, Ng K, Voutsinas J, Fromm JR, Dumenigo-Jimenez A, Martins RG, Eaton KD, Santana-Davila R, Baik C, Lee SM, Tseng D, Futran N, Barber B, Marchiano E, Laramore G, Lo SS, Liao JJ, Parvathaneni U

Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-NaĂŻve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Davids MS, Ryan CE, Lampson BL, Ren Y, Tyekucheva S, Fernandes SM, Crombie JL, Kim AI, Weinstock M, Montegaard J, Walker HA, Greenman C, Patterson V, Jacobson CA, LaCasce AS, Armand P, Fisher DC, Lo S, Olszewski AJ, Arnason JE, Ahn IE, Brown JR

Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma Cohort.

Braden J, Potter A, Rawson RV, Adegoke NA, Lo SN, Conway JW, Menzies AM, Carlino MS, Au-Yeung G, Saw RPM, Spillane AJ, Shannon KF, Pennington TE, Ch'ng S, Gyorki DE, Howle JR, Wilmott JS, Scolyer RA, Long GV, Pires da Silva I

The Impact of Race and Ethnicity on Location and Delivery of Palliative Radiotherapy.

Heng AK, Gooley T, Lo SS, Yang JT, Gillespie EF, Halasz LM, Tseng YD

Controlling Protein Immobilization over Poly(3-hydroxybutyrate) Microparticles Using Substrate Binding Domain from PHA Depolymerase.

Dias IP, da Cunha RS, Masaki R, Todo Bom MA, Ramos EAS, Dos Santos GJVP, Furman G, Lucena JT, Jiacomini IG, Lo SM, Schemczssen-Graeff Z, BeirĂŁo BCB, Zanata SM, Faria LML, Gerhardt EM, de Souza EM, MĂźller-Santos M, Picheth GF

Assessing Morbidity and Mortality in Adult Patients With Acute Traumatic Cervical Spinal Cord Injury Using a Modified Risk Analysis Index.

Elsamadicy AA, Serrato P, Belkasim S, Sayeed S, Hengartner AC, Sadeghzadeh S, Ghanekar S, Pennington Z, Khalid SI, Lo SL, Sciubba DM

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.

MahÊ I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, Sanchez O, Grange C, Monreal M, López-Núùez JJ, Otero-Candelera R, Le Gal G, Yeo E, Righini M, Robert-Ebadi H, Huisman MV, Klok FA, Westerweel P, Agnelli G, Becattini C, Bamias A, Syrigos K, Szmit S, Torbicki A, Verhamme P, Maraveyas A, Cohen AT, Ay C, Chapelle C, Meyer G, Couturaud F, Mismetti P, Girard P, Bertoletti L, Laporte S, API-CAT Investigators